Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

The Cancer Letter - Feb. 17, 2012

publication date: Feb 17, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
  • ODAC Votes to Nix Amgen's Drug Xgeva for Proposed Prostate Cancer Indication
  • Appropriations 2013: Obama Proposes Flat Funding for NIH
  • Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials


To access this members-only content, please log in.

If you're not a subscriber why not join today?

If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.